AstraZeneca, Amgen Score Phase 3 Win in Debilitating Swallowing Disease - Amgen (NASDAQ:AMGN), AstraZenec
The Zacks Analyst Blog Highlights Amgen, Thermo Fisher Scientific, PepsiCo, C&F Financial and Acorn Energy